A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin

被引：0
|
作者：
Michal Witkowski
Lars Wilkinson
Neil Webb
Alan Weids
Divina Glah
Hrvoje Vrazic
机构：
[1] DRG Abacus,
[2] Novo Nordisk A/S,undefined
[3] Novo Nordisk Ltd.,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Basal insulin; GLP-1 receptor agonist; Glycemic control; HbA; Network meta-analysis; Semaglutide; Systematic review; Systolic blood pressure; Type 2 diabetes; Weight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1233 / 1251
页数：18
相关论文
共 50 条
  • [21] Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis
    Nuhoho, Solomon
    Gupta, Jatin
    Hansen, Brian Bekker
    Fletcher-Louis, Mary
    Tam Dang-Tan
    Paine, Abby
    DIABETES THERAPY, 2019, 10 (06) : 2183 - 2199
  • [22] GLP-1 receptor agonists and basal insulin in type 2 diabetes
    Young, Laura A.
    Buse, John B.
    LANCET, 2014, 384 (9961): : 2180 - 2181
  • [23] Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis
    Chubb, Barrie
    Gupta, Palvi
    Gupta, Jatin
    Nuhoho, Solomon
    Kallenbach, Klaus
    Orme, Michelle
    DIABETES THERAPY, 2021, 12 (05) : 1325 - 1339
  • [24] Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis
    Barrie Chubb
    Palvi Gupta
    Jatin Gupta
    Solomon Nuhoho
    Klaus Kallenbach
    Michelle Orme
    Diabetes Therapy, 2021, 12 : 1325 - 1339
  • [25] Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes
    Di Dalmazi, Giulia
    Coluzzi, Sara
    Baldassarre, Maria Pompea Antonia
    Ghit, Amr
    Graziano, Giusi
    Rossi, Maria Chiara
    Ciappini, Beatrice
    Milo, Marica
    Carrieri, Federica
    Nicolucci, Antonio
    Consoli, Agostino
    Formoso, Gloria
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [26] Once-Weekly GLP-1 Receptor Agonists for the Management of Type 2 Diabetes: A Review of Clinical and Health Economic Data Introduction
    McGill, Janet
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (09): : S3 - S4
  • [27] Effectiveness and tolerability of once-weekly GLP-1 receptor agonists in clinical practice: a focus on switching between once-weekly molecules in type 2 diabetes
    Formoso, G.
    Di Dalmazi, G.
    Coluzzi, S.
    Baldassarre, M. P. A.
    Ghit, A.
    Graziano, G.
    Rossi, M. C.
    Ciappini, B.
    Milo, M.
    Carrieri, F.
    Nicolucci, A.
    Consoli, A.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S314 - S314
  • [28] Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysis
    Feng Sun
    Shanshan Wu
    Shuxia Guo
    Kai Yu
    Zhirong Yang
    Lishi Li
    Yuan Zhang
    Linong Ji
    Siyan Zhan
    Endocrine, 2015, 48 : 794 - 803
  • [29] Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysis
    Sun, Feng
    Wu, Shanshan
    Guo, Shuxia
    Yu, Kai
    Yang, Zhirong
    Li, Lishi
    Zhang, Yuan
    Ji, Linong
    Zhan, Siyan
    ENDOCRINE, 2015, 48 (03) : 794 - 803
  • [30] COST-UTILITY ANALYSIS OF ONCE-WEEKLY SEMAGLUTIDE VERSUS DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES REQUIRING TREATMENT WITH A GLP-1 RECEPTOR AGONIST
    Uranga, Garcia J.
    Jung, S.
    Dahaoui, Smeat
    VALUE IN HEALTH, 2022, 25 (12) : S160 - S160
12345